1Reyes BA, Beutner KR, Cullen SI, et al. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis. Int J Dermatol, 1998, 37:450-453
2Greer DL, Weiss J, Rodriguez DA, et al. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine,a new antifungal agent. J Am Acad Dermatol, 1997, 37(2 Pt 1):231-235.
3Lesher JL Jr, Babel DE, Stewart DM, et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled,double-blind trial. J Am Acad Dermatol, 1997, 36(2 Pt 1 ):S20-S24.
4Savin R, De Villez RL, Elewski B, et al. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial. J Am Acad Dermatol,1997, 36(2 Pt 1) :S15-S19.
5Tschen E, Elewski B, Gorsulowsky DC, et al. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. J Am Acad Dermatol, 1997, 36(2 Pt 1 ):S9-14.
6Odom RB. Update on topical therapy for superficial fungal infections: focus on butenafine. J Am Acad Dermatol, 1997, 36 (2 Pt1 ): S1-S2.
